Gerzenshtein J, Zhang F, Caplan J, Anand V, Lineaweaver W
Division of Plastic Surgery, University of Mississippi Medical Center, Jackson, MS, USA.
J Craniofac Surg. 2006 Jan;17(1):178-82. doi: 10.1097/01.scs.0000190350.37978.2c.
Ameloblastoma, the most common odontogenic tumor, is a slow growing, localized tumor of the facial skeleton. Eighty percent of the tumors affect the mandible. Treatment by wide excision is curative in 95% of cases. Reconstruction by bone grafting has a 20% to 30% nonunion rate. We have treated three large ameloblastomae (>6 cm) with fibula flaps, following resection. All patients have healed. With follow-up times of 2 to 3 years, there has been no evidence of recurrence and no difficulties with postoperative evaluation for recurrent disease. We conclude that the fibula flap is a reliable reconstructive operation following resection of large ameloblastomae.
成釉细胞瘤是最常见的牙源性肿瘤,是一种生长缓慢的面部骨骼局部肿瘤。80%的肿瘤发生在下颌骨。95%的病例通过广泛切除治疗可治愈。骨移植重建的骨不连发生率为20%至30%。我们在切除后用腓骨瓣治疗了3例大型成釉细胞瘤(>6 cm)。所有患者均已愈合。随访2至3年,没有复发迹象,术后对复发性疾病的评估也没有困难。我们得出结论,腓骨瓣是大型成釉细胞瘤切除术后可靠的重建手术。